GlycoMimetics Inc. (GLYC)
GlycoMimetics Statistics
Share Statistics
GlycoMimetics has 64.51M shares outstanding. The number of shares has increased by 0.08% in one year.
| Shares Outstanding | 64.51M |
| Shares Change (YoY) | 0.08% |
| Shares Change (QoQ) | 0.05% |
| Owned by Institutions (%) | 47.07% |
| Shares Floating | 56.1M |
| Failed to Deliver (FTD) Shares | 17 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 2.46M, so 3.82% of the outstanding shares have been sold short.
| Short Interest | 2.46M |
| Short % of Shares Out | 3.82% |
| Short % of Float | 4.62% |
| Short Ratio (days to cover) | 10.31 |
Valuation Ratios
The PE ratio is 0 and the forward PE ratio is -7.99. GlycoMimetics's PEG ratio is 0.
| PE Ratio | 0 |
| Forward PE | -7.99 |
| PS Ratio | 0 |
| Forward PS | 1.1 |
| PB Ratio | 0 |
| P/FCF Ratio | 0 |
| PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for GlycoMimetics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.92 |
| Quick Ratio | 1.92 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $0 |
| Employee Count | 4 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -85.38% in the last 52 weeks. The beta is 1.74, so GlycoMimetics's price volatility has been higher than the market average.
| Beta | 1.74 |
| 52-Week Price Change | -85.38% |
| 50-Day Moving Average | 0.25 |
| 200-Day Moving Average | 0.25 |
| Relative Strength Index (RSI) | 60.33 |
| Average Volume (20 Days) | 1.44M |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -40.04B |
| Net Income | 0 |
| EBITDA | -40.04B |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.59 |
Balance Sheet
The company has 10.72M in cash and 66.84M in debt, giving a net cash position of -56.12M.
| Cash & Cash Equivalents | 10.72M |
| Total Debt | 66.84M |
| Net Cash | -56.12M |
| Retained Earnings | -494.36B |
| Total Assets | 11.09M |
| Working Capital | 5.31M |
Cash Flow
In the last 12 months, operating cash flow was -31.1B and capital expenditures -9.97K, giving a free cash flow of -31.11B.
| Operating Cash Flow | -31.1B |
| Capital Expenditures | -9.97K |
| Free Cash Flow | -31.11B |
| FCF Per Share | -482.47 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GLYC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for GLYC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -69.96 |
| Piotroski F-Score | 1 |